[
  {
    "ts": "2025-09-03T12:02:00+00:00",
    "headline": "Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs",
    "summary": "Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the closing of a $59 million series B financing. The round was co-led by Novalis and Sozo Ventures, with participation from Perceptive Xontogeny Venture Fund, American Cancer Society BrightEdge and iSelect Fund, as well as funds committed to women's health and leadership including Portfolia, Avestria Ventures, and Mindshift Capital. The round also included signifi",
    "url": "https://finance.yahoo.com/news/mercy-bioanalytics-announces-59-million-120200783.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "782c666c-f050-3712-a255-ec22d66997ab",
      "content": {
        "id": "782c666c-f050-3712-a255-ec22d66997ab",
        "contentType": "STORY",
        "title": "Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs",
        "description": "",
        "summary": "Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the closing of a $59 million series B financing. The round was co-led by Novalis and Sozo Ventures, with participation from Perceptive Xontogeny Venture Fund, American Cancer Society BrightEdge and iSelect Fund, as well as funds committed to women's health and leadership including Portfolia, Avestria Ventures, and Mindshift Capital. The round also included signifi",
        "pubDate": "2025-09-03T12:02:00Z",
        "displayTime": "2025-09-03T12:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/4ee0e96538779c5e48b88c8d50192afe",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "Mercy BioAnalytics (PRNewsfoto/Mercy BioAnalytics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z0A7KnEnq0UbCoElN5.ZAA--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4ee0e96538779c5e48b88c8d50192afe.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wKR2NZNCJeTHTIeYtubnaw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4ee0e96538779c5e48b88c8d50192afe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mercy-bioanalytics-announces-59-million-120200783.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mercy-bioanalytics-announces-59-million-120200783.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOLX"
            },
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]